Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17)

NCT01190813 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT01190813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01190813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17)
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
April 30, 2014
Enrollment
139 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amblyopia